Seeking AlphaTue, 12 May 2026 17:21:39 GMTMirum Pharmaceuticals: A Rare Disease Platform Becoming Bigger Than Its First FranchiseMIRM-2.04%
Zacks Investment ResearchThu, 07 May 2026 17:06:08 GMTMirum's Q1 Earnings & Revenues Beat Estimates, 2026 View RaisedMIRM-2.04%
Seeking AlphaThu, 07 May 2026 03:21:14 GMTMirum Pharmaceuticals, Inc. (MIRM) Q1 2026 Earnings Call TranscriptMIRM-2.04%
Zacks Investment ResearchWed, 06 May 2026 23:01:14 GMTHere's What Key Metrics Tell Us About Mirum Pharmaceuticals (MIRM) Q1 EarningsMIRM-2.04%
Zacks Investment ResearchWed, 06 May 2026 22:25:37 GMTMirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Beats Revenue EstimatesMIRM-2.04%
Seeking AlphaTue, 05 May 2026 00:43:41 GMTMirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Clinical Results in Primary Sclerosing Cholangitis and Hepatitis Delta TranscriptMIRM-2.04%
BenzingaMon, 04 May 2026 15:15:10 GMTMirum Pharmaceuticals Rally Reflects Confidence In Late-Stage Liver Disease AssetsMIRM-2.04%
Zacks Investment ResearchFri, 17 Apr 2026 16:41:20 GMTWill Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings?MIRM-2.04%
The Motley FoolMon, 13 Apr 2026 09:43:00 GMTPrediction: Buying This Biotech Stock Today Could Set You Up for LifeMIRM-2.04%
Zacks Investment ResearchWed, 01 Apr 2026 13:10:29 GMTMirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last?MIRM-2.04%
Zacks Investment ResearchFri, 27 Mar 2026 16:31:44 GMTWhy Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report?MIRM-2.04%
Zacks Investment ResearchTue, 17 Mar 2026 16:40:47 GMTMirum Completes Enrollment in Late-Stage EXPAND Study of LivmarliMIRM-2.04%
Zacks Investment ResearchFri, 06 Mar 2026 14:30:26 GMTMirum Completes Enrollment & Screening in Liver Disease StudiesMIRM-2.04%
Zacks Investment ResearchThu, 26 Feb 2026 16:51:06 GMTMirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y RevenuesMIRM-2.04%
Zacks Investment ResearchThu, 26 Feb 2026 02:01:12 GMTMirum Pharmaceuticals (MIRM) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesMIRM-2.04%
Zacks Investment ResearchThu, 26 Feb 2026 01:25:29 GMTMirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue EstimatesMIRM-2.04%
Seeking AlphaWed, 25 Feb 2026 23:37:54 GMTMirum Pharmaceuticals, Inc. (MIRM) Q4 2025 Earnings Call TranscriptMIRM-2.04%
